Table 1 Baseline characteristics
CharacteristicBMS1BMS2SESp Value
Cases7610
Age (years)61.0 (10.49)64.2 (7.78)58.3 (9.82)0.50
Time post-stenting (months)7.29 (2.06)44.50 (24.56)8.60 (2.72)<0.0001*
Male sex6680.51
Stent diameter (mm)3.03 (0.34)3.04 (0.25)3.05 (0.28)0.99
Stent length (mm)18.75 (3.77)17.50 (3.99)22.00 (6.03)0.15
Hypertension5680.38
Diabetes mellitus1260.16
Smoking3560.33
CHO (mmol/l)4.33 (0.88)4.03 (0.36)4.51 (1.13)0.50
TG (mmol/l)1.37 (0.52)2.08 (1.03)2.00 (1.53)0.77
HDL (mmol/l)0.91 (0.43)1.04 (0.09)1.03 (0.22)0.80
LDL (mmol/l)2.81 (0.69)2.35 (0.22)2.88 (0.97)0.39
OCT target vessel
LAD4490.24
LCX103
RCA220
  • BMS1 group, bare-metal stent with 5–10 months follow-up; BMS2 group, bare-metal stent with 23–93 months follow-up; SES group, sirloimus-eluting stent with 6–12 months of follow-up; cholesterol (CHO); triglyceride (TG); high-density lipoprotein cholesterol (HDL); low-density lipoprotein cholesterol (LDL); OCT, optical coherence tomography; left anterior descending artery (LAD); left circumflex artery (LCX); right coronary artery (RCA).*Within three groups, p<0.0001; BMS1 vs SES, p = NS.